Core Viewpoint - The company, China Merchants China Fund, has announced an investment of 15 million RMB in Boreas Technology (Shanghai) Co., Ltd. as part of its E-round financing, aiming to enhance its portfolio in the medical sector [1] Group 1: Investment Details - The investment agreement was signed on October 28, 2025, and the funding was completed on November 7, 2025 [1] - The investment amount is 15 million RMB, which is approximately 2.1 million USD [1] Group 2: Company Overview - Boreas Technology, established in November 2011, specializes in brain-machine interface technology and is recognized as a high-tech enterprise in mainland China [1] - The company focuses on the research, development, production, and sales of brain-machine interface systems and related technical services [1] Group 3: Market Applications - Boreas Technology's products are applicable in various fields, including neuroscience, psychology, human factors engineering, kinesiology, and management science [1] - The company's innovations also cater to clinical applications for diagnosing, treating, and rehabilitating neurological diseases, gaining recognition from experts in both domestic and international medical fields [1] Group 4: Strategic Implications - The investment in Boreas Technology is expected to increase the proportion of medical-related projects within the company's investment portfolio, optimizing its overall investment strategy [1]
招商局中国基金(00133)出资1500万元投资博睿康技术